Roberts; Patrick Joseph

Patent Applications and Registrations

Patent applications and USPTO patent grants for Roberts; Patrick Joseph.The latest application filed is for "treatment of rb-negative tumors using topoisomerase inhibitors in combination with cyclin dependent kinase 4/6 inhibitors".

Company Profile

17.18.43

Roberts; Patrick Joseph - Durham NC
Roberts; Patrick Joseph - Research Triangle Park NC

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Anti-neoplastic combinations and dosing regimens using CDK4/6 inhibitor compounds to treat Rb-positive tumors Grant 11,446,295 - Strum , et al. September 20, 2	2022-09-20
Treatment Of Rb-negative Tumors Using Topoisomerase Inhibitors In Combination With Cyclin Dependent Kinase 4/6 Inhibitors App 20220175780 - Strum; Jay Copeland ; et al.	2022-06-09
Patient Selection For Enhancement Of Anti-tumor Immunity In Cancer Patients App 20220175787 - Roberts; Patrick Joseph ; et al.	2022-06-09
Transient Protection Of Normal Cells During Chemotherapy App 20210299130 - Strum; Jay Copeland ; et al.	2021-09-30
Therapeutic Regimens For Treatment Of Cancer Using Eribulin And Selective Cdk4/6 Inhibitor Combinations App 20210267986 - Sorrentino; Jessica A. ; et al.	2021-09-02
Treatment of Rb-negative tumors using topoisomerase inhibitors in combination with cyclin dependent kinase 4/6 inhibitors Grant 11,090,306 - Strum , et al. August 17, 2	2021-08-17
Hspc-sparing Treatments For Rb-positive Abnormal Cellular Proliferation App 20210213022 - Strum; Jay Copeland ; et al.	2021-07-15
Transient protection of normal cells during chemotherapy Grant 11,040,042 - Strum , et al. June 22, 2	2021-06-22
Transient protection of normal cells during chemotherapy Grant 10,966,984 - Strum , et al. April 6, 2	2021-04-06
Transient Protection Of Hematopoietic Stem And Progenitor Cells Against Ionizing Radiation App 20210077498 - Strum; Jay Copeland ; et al.	2021-03-18
HSPC-sparing treatments for RB-positive abnormal cellular proliferation Grant 10,925,878 - Strum , et al. February 23, 2	2021-02-23
Treatment Of Cancers Having Driving Oncogenic Mutations App 20210030758 - Strum; Jay Copeland ; et al.	2021-02-04
Transient Protection Of Normal Cells During Chemotherapy App 20200345742 - Strum; Jay Copeland ; et al.	2020-11-05
Highly Active Anti-neoplastic And Anti-proliferative Agents App 20200345743 - Strum; Jay Copeland ; et al.	2020-11-05
Highly active anti-neoplastic and anti-proliferative agents Grant 10,709,711 - Strum , et al.	2020-07-14
Transient protection of normal cells during chemotherapy Grant 10,660,896 - Strum , et al.	2020-05-26
Treatment Of Rb-negative Tumors Using Topoisomerase Inhibitors In Combination With Cyclin Dependent Kinase 4/6 Inhibitors App 20200022983 - Strum; Jay Copeland ; et al.	2020-01-23
Preservation Of Immune Response During Chemotherapy Regimens App 20190321370 - Sorrentino; Jessica A. ; et al.	2019-10-24
HSPC-sparing treatments for Rb-positive abnormal cellular proliferation Grant 10,434,104 - Strum , et al. O	2019-10-08
Treatment of Rb-negative tumors using topoisomerase with cyclin dependent kinase 4/6 inhibitors Grant 10,413,547 - Strum , et al. Sept	2019-09-17
Tricyclic lactams for use in HSPC-sparing treatments for Rb-positive abnormal cellular proliferation Grant 10,376,519 - Strum , et al. A	2019-08-13
Transient Protection Of Hematopoietic Stem And Progenitor Cells Against Ionizing Radiation App 20190167691 - Strum; Jay Copeland ; et al.	2019-06-06
Anti-neoplastic Combinations And Dosing Regimens Using Cdk4/6 Inhibitor Compounds To Treat Rb-positive Tumors App 20190151311 - Strum; Jay Copeland ; et al.	2019-05-23
Highly Active Anti-Neoplastic and Anti-Proliferative Agents App 20190125752 - Strum; Jay Copeland ; et al.	2019-05-02
Anti-neoplastic combinations and dosing regimens using CDK4/6 inhibitor compounds to treat RB-positive tumors Grant 10,231,969 - Strum , et al.	2019-03-19
Hspc-sparing Treatments For Rb-positive Abnormal Cellular Proliferation App 20190070185 - Strum; Jay Copeland ; et al.	2019-03-07
Treatment Of Rb-negative Tumors Using Topoisomerase Inhibitors In Combination With Cyclin Dependent Kinase 4/6 Inhibitors App 20190030034 - Strum; Jay Copeland ; et al.	2019-01-31
Hspc-sparing Treatments For Rb-positive Abnormal Cellular Proliferation App 20180360841 - Strum; Jay Copeland ; et al.	2018-12-20
Transient Protection Of Normal Cells During Chemotherapy App 20180360840 - Strum; Jay Copeland ; et al.	2018-12-20
Transient Protection Of Hematopoietic Stem And Progenitor Cells Against Ionizing Radiation App 20180303838 - Strum; Jay Copeland ; et al.	2018-10-25
Transient protection of normal cells during chemotherapy Grant 10,085,992 - Strum , et al. October 2, 2	2018-10-02
HSPC-sparing treatments for RB-positive abnormal cellular proliferation Grant 10,076,523 - Strum , et al. September 18, 2	2018-09-18
Transient Protection Of Normal Cells During Chemotherapy App 20180221378 - Strum; Jay Copeland ; et al.	2018-08-09
Transient protection of normal cells during chemotherapy Grant 9,931,345 - Strum , et al. April 3, 2	2018-04-03
Highly Active Anti-neoplastic And Anti-proliferative Agents App 20180015096 - Strum; Jay Copeland ; et al.	2018-01-18
Tricyclic Lactams For Use In Hspc-sparing Treatments For Rb-positive Abnormal Cellular Proliferation App 20170333440 - Strum; Jay Copeland ; et al.	2017-11-23
Treatment Of RB-Negative Tumors Using Topoisomerase Inhibitors In Combination With Cyclin Dependent Kinase 4/6 Inhibitors App 20170246171 - Strum; Jay Copeland ; et al.	2017-08-31
Tricyclic lactams for use in HSPC-sparing treatments for RB-positive abnormal cellular proliferation Grant 9,717,735 - Strum , et al. August 1, 2	2017-08-01
Anti-Neoplastic Combinations and Dosing Regimens using CDK4/6 Inhibitor Compounds to Treat RB-Positive Tumors App 20170182043 - Strum; Jay Copeland ; et al.	2017-06-29
Transient Protection of Hematopoietic Stem and Progenitor Cells Against Ionizing Radiation App 20170119774 - Strum; Jay Copeland ; et al.	2017-05-04
HSPC-Sparing Treatments for RB-Positive Abnormal Cellular Proliferation App 20170100405 - Strum; Jay Copeland ; et al.	2017-04-13
Transient Protection of Normal Cells During Chemotherapy App 20170065597 - Strum; Jay Copeland ; et al.	2017-03-09
Transient Protection Of Normal Cells During Chemotherapy App 20170037051 - Strum; Jay Copeland ; et al.	2017-02-09
HSPC-sparing treatments for RB-positive abnormal cellular proliferation Grant 9,527,857 - Strum , et al. December 27, 2	2016-12-27
Transient protection of normal cells during chemotherapy Grant 9,487,530 - Strum , et al. November 8, 2	2016-11-08
Highly Active Anti-Neoplastic and Anti-Proliferative Agents App 20160310499 - Strum; Jay Copeland ; et al.	2016-10-27
Transient protection of normal cells during chemotherapy Grant 9,464,092 - Strum , et al. October 11, 2	2016-10-11
CDK4/6 Inhibitor Dosage Formulations For The Protection Of Hematopoietic Stem And Progenitor Cells During Chemotherapy App 20160220569 - Strum; Jay Copeland ; et al.	2016-08-04
Transient Protection of Hematopoietic Stem and Progenitor Cells Against Ionizing Radiation App 20160045509 - Strum; Jay Copeland ; et al.	2016-02-18
Tricyclic Lactams for Use as Anti-Neoplastic and Anti-Proliferative Agents App 20150297608 - Strum; Jay Copeland ; et al.	2015-10-22
Tricyclic Lactams for Use in the Protection of Hematopoietic Stem and Progenitor Cells Against Ionizing Radiation App 20150297606 - Strum; Jay Copeland ; et al.	2015-10-22
Tricyclic Lactams for Use in the Protection of Normal Cells During Chemotherapy App 20150297607 - Strum; Jay Copeland ; et al.	2015-10-22
Tricyclic Lactams for Use in HSPC-Sparing Treatments for RB-Positive Abnormal Cellular Proliferation App 20150299212 - Strum; Jay Copeland ; et al.	2015-10-22
Hematopoietic Protection Against Chemotherapeutic Compounds Using Selective Cyclin-dependent Kinase 4/6 Inhibitors App 20150111896 - Sharpless; Norman Edward ; et al.	2015-04-23
HSPC-Sparing Treatments for RB-Positive Abnormal Cellular Proliferation App 20140271466 - Sharpless; Norman E. ; et al.	2014-09-18
Highly Active Anti-Neoplastic and Anti-Proliferative Agents App 20140271460 - Sharpless; Norman E. ; et al.	2014-09-18
Transient Protection of Hematopoietic Stem and Progenitor Cells Against Ionizing Radiation App 20140274896 - Sharpless; Norman E. ; et al.	2014-09-18
Transient Protection of Normal Cells During Chemotherapy App 20140275067 - Sharpless; Norman E. ; et al.	2014-09-18
Transient Protection of Normal Cells During Chemotherapy App 20140275066 - Sharpless; Norman E. ; et al.	2014-09-18
Protection Of Renal Tissues From Ischemia Through Inhibition Of The Proliferative Kinases Cdk4 And Cdk6 App 20130303543 - DiRocco; Derek Paul ; et al.	2013-11-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.